News Headlines Article

Drugmaker to donate HIV-prevention pills for as many as 200,000 people
Washington Post

The pharmaceutical company that makes a once-a-day pill that protects users against HIV has agreed to donate enough medication to cover as many as 200,000 people for 11 years, the Trump administration announced Thursday.

Gilead Sciences, the maker of Truvada, will donate as many as 2.4 million bottles of the costly drug each year to the Centers for Disease Control and Prevention, which will distribute the medication to uninsured people at high risk of contracting HIV. A year’s supply of the pills, known as pre-exposure prophylaxis, or PrEP, costs more than $20,000.